TRV Gp, LLC, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 1,650,000 shares at $18.00 ($28.7M) on 2017-03-27, disclosed to the SEC on 2017-03-27.
Open-market sale of $28.7M CTMX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.00 | 1,000,000 | $17.0M | 59.2% |
| 2 | $18.00 | 650,000 | $11.7M | 40.8% |
| Total | $17.39 avg | 1,650,000 | $28.7M | 100% |
| Filing → |